Universitair Ziekenhuis Brussel: Melanoma trials
The registry lists 11 Melanoma studies with Universitair Ziekenhuis Brussel as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 4Phase 2 8No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.RecruitingNCT07448831Phase 2
- Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.RecruitingNCT02907827Not applicable
- Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced MelanomaRecruitingNCT02673970
- A Clinical Trial of Regorafenib in Patients With Pretreated Advanced MelanomaActive, not recruitingNCT05370807Phase 2
- Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CTTerminatedNCT04168528Phase 1/2
- TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type MelanomaCompletedNCT04059224Phase 2
- Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant MelanomaStatus unknownNCT03754179Phase 1/2
- Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC)Status unknownNCT03747744Phase 1
- A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma MacrometastasesCompletedNCT02941744Phase 1/2
- Dabrafenib and Trametinib for BRAF-inhibitor Pretreated PatientsCompletedNCT02296996Phase 2
- mRNA Electroporated Autologous Dendritic Cells for Stage III/IV MelanomaCompletedNCT01676779Phase 2